GC
Genesys Capital
Venture CapitalActiveGenesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology.
27
Investments
7
Exits
$500M
AUM
25.9%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Genesys Capital.
Investment Thesis & Strategy
Genesys Capital invests in various stages of healthcare and biotechnology companies, seeking high-growth opportunities within the life sciences sector.
Investment Activity
Deals per year over the last 14 years
1
20080
20090
20101
20110
20120
20132
20140
20150
20160
20172
20181
20190
20203
2021Portfolio Companies
Selected investments from their portfolio of 27 companies
F
Field Trip Health
Healthcare · Growth, 2021
Z
Zucara Therapeutics
Biotech · Series A, 2021
E
Encycle Therapeutics
Biotech · Series A, 2021
V
Vasomune Therapeutics
Biotech · Series A, 2019
F
Fusion Pharmaceuticals
Biotech · Series A, 2018
C
Cyclica
Biotech · Series A, 2018
N
Novelion Therapeutics
Biotech · Series B, 2014
P
ProMIS Neurosciences
Biotech · Series A, 2014
T
Therapure Biopharma
Biotech · Growth, 2011
M
Medicago
Biotech · Growth, 2008
Notable Exits
CompanyTypeYearValue / Acquirer
ZymeworksIPO2017—
Novelion TherapeuticsIPO2014—
Enobia PharmaAcquisition2012$1B
Angiotech PharmaceuticalsAcquisition2011—
SemBioSys GeneticsIPO2010—
VasogenAcquisition2010—
Aspreva PharmaceuticalsAcquisition2007—
Frequently Asked Questions
Genesys Capital focuses on Series A, Series B, Series C+ stage investments.